Tomasz Zatonski | Public Health | Research Excellence Award

Published on by Research Data Analysis

Prof. Tomasz Zatonski | Public Health | Research Excellence Award

Wroclaw Medical University | Poland

Prof. Tomasz Zatoński is a distinguished otolaryngologist and Associate Professor at the Medical University of Wrocław, Poland, currently serving as Vice-Rector for University Communications and Head of the Department of Otolaryngology-Head and Neck Surgery. He earned his MD from the Medical University of Wrocław, followed by specialization in otolaryngology, a doctoral degree on DNA ploidy analysis in laryngeal cancer, and a habilitation focusing on the role of HPV and cell cycle proteins in head and neck carcinogenesis. With a prolific research profile, Prof. Zatoński has authored 112 documents cited 1,551 times by 1,530 documents and holds an h-index of 20. His research interests focus on HPV-associated head and neck cancers, surgical oncology, endolaryngeal microsurgery, tumor markers, and carcinogenesis mechanisms. He has participated in numerous international observerships, teaching courses, and conferences in the USA, India, Israel, and Europe, and has been recognized with multiple awards for teaching, research, and service, including honors from the Medical University of Wrocław and the Minister of Health. Prof. Zatoński leads and contributes to significant national and international grants, including population cohort studies and biomedical research projects. His work integrates clinical expertise with translational research, advancing knowledge in head and neck oncology and improving patient care and outcomes globally.

Profiles : Scopus | Orcid

Featured Publications

📄 Fibrous Dysplasia of the Ethmoid Bone Diagnosed in a 10‑Year‑Old Patient
Zofia Resler, Monika Morawska‑Kochman, Katarzyna Resler, Tomasz Zatoński — Medicina (2025)
Open access case report of rare fibrous dysplasia in a child, including clinical presentation and management.
🔗 Read full text

📄 Multinational Attitudes Toward AI in Health Care and Diagnostics Among Hospital Patients
F. Busch et al. — JAMA Network Open (2025)
Large international survey exploring patient trust, preferences, and concerns regarding AI use in health care and diagnostics.
🔗 Read full text

📄 Age‑related Hearing Loss Associated With Cognitive Impairment in the Polish Cohort of the PURE Study
Połtyn‑Zaradna K., Pazdro‑Zastawny K., Szcześniak D., et al. — Frontiers in Aging Neuroscience (2025)
Open access study linking presbycusis (age‑related hearing loss) with cognitive impairment in a Polish adult cohort.
🔗 Read full text

📄 Fabrication and Comprehensive Evaluation of Zr‑Based Bulk Metallic Glass Matrix Composites for Biomedical Applications
Science China Materials (2024)
Open access materials science research on zirconium‑based bulk metallic glass composites relevant to biomedical implants and applications.
🔗 Search on journal site

📄 Hypertension in Adult Population Under 50 in the Population Cohort Study of Wroclaw Citizens (PICTURE): Prevalent, Undetected, and Mostly Preventable
Critical Public Health (2025)
Open access population health article examining the epidemiology and prevention potential for hypertension in younger adults.
🔗 Search on journal site

Somnath Roy | Medical Oncology | Research Excellence Award

Published on by Research Data Analysis

Dr. Somnath Roy | Medical Oncology | Research Excellence Award

Tata Medical Center, Kolkata | India

Dr. Somnath Roy is a distinguished medical oncologist with a strong academic foundation and extensive clinical experience in leading oncology centers in India. He completed his MBBS from North Bengal Medical College, followed by a PG Diploma and MD in Radiotherapy from WBUHS, and later earned his DM in Medical Oncology from Homi Bhabha National Institute, Mumbai. His professional journey includes serving as Junior and Senior Resident at IPGMER & SSKM Hospital, Kolkata, and subsequently as Senior Resident at Tata Memorial Hospital, Mumbai, where he strengthened his expertise in multidisciplinary cancer care. Dr. Roy’s research background is notable, holding the European Certificate in Medical Oncology (ECMO), MRCP(UK) Specialty Certificate in Medical Oncology, and DNB in Medical Oncology. He has actively led multiple Phase III clinical trials as Principal Investigator in prostate, breast, lung, and ovarian cancers. His scholarly impact includes 94 citations across 90 documents, 27 publications, and an h-index of 6, reflecting meaningful contributions to oncology literature. His key research interests span solid tumors, novel therapeutics, precision oncology, and clinical trial development. Recognized for his commitment to evidence-based practice and academic excellence, Dr. Roy continues to advance high-quality cancer care and research with dedication and integrity.

Profile : Scopus 

Featured Publications

Primary Mediastinal Germ Cell Tumors: A Real-World Analysis of Clinical Characteristics, Treatment, and Survival Outcomes From Two Tertiary Cancer Centers in India
JCO Global Oncology, 2025

Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer
European Journal of Cancer, 2024

Vaishali Sharma | Neuroscience Data Analysis | Best Researcher Award

Published on by Research Data Analysis

Dr. Vaishali Sharma | Neuroscience Data Analysis | Best Researcher Award

Post Graduate Institue of Medical Education and Research (PGIMER) | India

Dr. Vaishali Sharma is a Senior Research Fellow at the Department of Neurology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, specializing in neurobiology, neuroinflammation, and sleep disorders. She earned her Ph.D. in Neurology (2020–2025) from PGIMER, focusing on the role of aquaporins, heat shock proteins, and neuroinflammatory markers in idiopathic intracranial hypertension (IIH) and their correlation with clinical parameters. She also holds a master’s degree in Zoology and a bachelor’s in Medical Science. Her research encompasses molecular biomarkers, blood-brain barrier disruption, circadian rhythm disturbances, and the evaluation of sleep and headache disorders, combining clinical, translational, and systematic review approaches. Dr. Sharma has contributed to multiple peer-reviewed publications and conference presentations, investigating psychiatric and sleep abnormalities, migraine care, and IIH pathophysiology. She has been recognized with several awards and fellowships, including CSIR and ICMR travel grants, best poster awards, and national and international research fellowships. Her professional activities extend to academic leadership and organizing conferences in neuro-ophthalmology and neurology. Dr. Sharma’s work advances the understanding of neuroinflammatory mechanisms, sleep disorders, and headache pathophysiology, providing insights for improved diagnosis, treatment, and quality of life for patients with neurological disorders.

Profile : Google Scholar

Featured Publications

Choudhary, N., Kumar, A., Sharma, V., Kaur, K., Kharbanda, P. S., Baishya, J., et al. (2024). “Effectiveness of CBT for reducing depression and anxiety in people with epilepsy: A systematic review and meta-analysis of randomized controlled trials.” Epilepsy & Behavior, 151, 109608.

Sharma, V., Chakravarty, K., Ray, S., Lal, V., & Takkar, A., Kharbanda, P. (2021). “Evaluation of prevalence and severity of obstructive sleep apnea using overnight-polysomnography in patients with idiopathic intracranial hypertension.” Journal of the Neurological Sciences, 429.

Sharma, V., Chakravarty, K., & Ray, S. (2023). “Questionnaire-based evaluation of sleep abnormality in patients with primary headache disorder: A cross-sectional study from tertiary care centre.” Journal of the Neurological Sciences, 455.

Sharma, S. R. V., & Chakravarty, K. (2023). “Questionnaire-based assessment of sleep abnormalities in patients with migraine: A cross-sectional study with a comparison group.” Annals of Indian Academy of Neurology, 26, S186.

Sharma, A. T. K., Chakravarty, K., Lal, V., & Kharbanda, P. S., et al. (2022). “Sleep and headache characteristics in patients with idiopathic intracranial hypertension (IIH) – An observational study.” Annals of Indian Academy of Neurology, 25, S296–S297.

Lan Xie | COVID-19 Analysis | Research Excellence Award

Published on by Research Data Analysis

Assoc. Prof. Dr. Lan Xie | COVID-19 Analysis | Research Excellence Award

Tsinghua University | China

Assoc. Prof. Dr. Lan Xie is a leading researcher in drug discovery and traditional Chinese medicine (TCM) integration with modern biomedical technologies. She earned her M.D. in Clinical Medicine from Peking University and a Ph.D. in Biology from Tsinghua University. Dr. Xie completed postdoctoral training at Tsinghua University and a visiting scholar program at the University of Pittsburgh. She has held faculty positions at Tsinghua University since 2014, currently serving as Associate Professor at the School of Basic Medical Sciences. Her research focuses on combining TCM with systems biology, multi-omics, and artificial intelligence to develop novel therapeutic strategies. She pioneered the Molecular Materia Medica database and an intelligent TCM formulation algorithm leveraging gene expression profiles and dysregulated disease pathways. Her work has been recognized with numerous awards, including the Huaxia Medical Science and Technology Award, International Award for Contribution to Chinese Medicine, and multiple Tsinghua University teaching excellence awards. Dr. Xie’s research achievements encompass high-throughput TCM bioactive component screening, single-cell omics-based mechanistic studies, and pathway-guided intelligent drug formulation. With 1,716 citations by 47 documents, 47 publications, and an h-index of 24, her contributions continue to advance modern medicine by bridging traditional knowledge and cutting-edge technology.

Profile : Scopus

Featured Publications

“A universal gene expression signature-based strategy for the high-throughput discovery of anti-inflammatory drugs.” Inflammation Research. 2025.

“Identification of the fruit of Brucea javanica as an anti-liver fibrosis agent working via SMAD2/SMAD3 and JAK1/STAT3 signaling pathways.” Journal of Pharmaceutical Analysis. 2025.

“Pulsatilla chinensis functions as a novel antihyperlipidemic agent by upregulating LDLR in an ERK-dependent manner.” Chinese Medicine United Kingdom. 2024.

“Mechanism study of Xiaoyao San against nonalcoholic steatohepatitis-related liver fibrosis based on a combined strategy of transcriptome analysis and network pharmacology.” Pharmaceuticals. 2024.

Lining Huang | Bioinformatics | Research Excellence Award

Published on by Research Data Analysis

Mr. Lining Huang | Bioinformatics | Research Excellence Award

The Second Hospital of Hebei Medical University | China

Dr. Huang is a distinguished researcher and attending physician specializing in perioperative neuroscience, with a Ph.D. in anesthesiology from Hebei Medical University. His career has centered on elucidating the molecular pathways through which blood–brain barrier dysfunction contributes to neurocognitive decline in aging surgical populations. Integrating molecular biology, neuroimaging, immunology, and microbiome science, he has established a multidisciplinary research program that advances understanding of the vascular–immune mechanisms driving perioperative neurocognitive disorders. From anesthesia-induced neurotoxicity in early studies to complex “vascular-immune–microbiome” interactions in recent work, his contributions span preclinical models, translational investigations, and clinical cohort studies. He has served as principal investigator on more than ten major funded projects, including multiple National Natural Science Foundation of China grants, and has earned notable distinctions such as the Hebei Province Science and Technology Progress Award and several first-prize Hebei Medical Science Awards. His commitment to academic scholarship includes translating Miller’s Anesthesia, editing national textbooks, and co-authoring expert consensus guidelines that shape anesthesiology education and practice nationwide. With a portfolio of influential publications and six national patents in airway-management innovations, Dr. Huang continues to advance therapeutic development and scientific knowledge in surgical brain protection and perioperative cognitive health.

Profile : Scopus

Featured Publications

SPP1-mediated crosstalk between macrophages and fibroblasts promotes benign airway stenosis. (2025). Archives of Biochemistry and Biophysics.

Association between preoperative blood–brain barrier permeability and postoperative delirium in older patients undergoing cardiac surgery: a pilot study. (2025). Aging Clinical and Experimental Research.

Central neuropeptides as key modulators of astrocyte function in neurodegenerative and neuropsychiatric disorders. (2025).

Neonatal sevoflurane exposure disrupted fatty acids metabolism, leading to hypomyelination and neurological impairments. (2025). Biomedicine and Pharmacotherapy.

Diamant Thaci | Emerging Research Trends | Best Researcher Award

Published on by Research Data Analysis

Prof. Dr. Diamant Thaci | Emerging Research Trends | Best Researcher Award

Universität zu Lübeck | Germany

Prof. Dr. med. Diamant Thaçi is a leading dermatologist and inflammation medicine expert whose career spans clinical practice, translational research, and academic leadership. After completing a postdoctoral fellowship and receiving a DAAD Scholarship for highly talented young scientists, he specialized in dermatology and venereology and advanced through key roles at J.W. Goethe University Frankfurt, including Senior Physician for dermatological clinical research and chronic inflammatory skin diseases. He later earned his venia legendi and held a W2 Professorship before assuming major leadership positions at the University of Lübeck, where he currently directs the Institute for Inflammation Medicine, the Excellence Center for Inflammation Medicine, and the Inflammation Board. His research focuses on atopic dermatitis, psoriasis, psoriatic arthritis, and novel immunomodulatory therapies, contributing extensively to pivotal international clinical trials. With 379 documents, 20,448 citations by 13,334 documents, and an h-index of 68, he is recognized as a Highly Cited Researcher and serves on multiple international councils and editorial boards. His awards include the Theodor Stern Foundation Prize and multiple distinctions from EADV and other societies. Overall, he is regarded as one of the most influential figures in modern inflammation and dermatology research.

Profiles : Scopus | Orcid

Featured Publications

Curman, P., Thaçi, D., & Ludwig, R. J. (2025). “Increased Cardiovascular Risk in Chronic Spontaneous Urticaria: A Large Real-World Cohort Study” in Allergy.

Lebwohl, M., Gooderham, M. J., Warren, R. B., Thaçi, D., Foley, P., Gottlieb, A. B., Torres, T., Popmihajlov, Z., Jou, Y.-M., Linaberry, M., et al. (2025). “Outcomes of Psoriasis Area and Severity Index (PASI) and PASI components in two phase III trials of deucravacitinib in patients with moderate to severe plaque psoriasis” in Clinical and Experimental Dermatology.

Olbrich, H., Kridin, K., Zirpel, H., Hernandez, G., Sadik, C. D., Gaffal, E., Thaçi, D., & Ludwig, R. J. (2025). “Glucagon-like peptide-1 receptor agonists and reduced mortality, cardiovascular and psychiatric risks in patients with psoriasis: a large-scale cohort study” in British Journal of Dermatology.

Alfarsi, S., Recke, A., Gaffal, E., Klein, J. P., Zirpel, H., Kridin, K., Thaçi, D., Olbrich, H., Bieber, K., & Ludwig, R. J. (2025). “Increased risk of psychiatric disease in patients with prurigo nodularis” in British Journal of Dermatology.

Thaçi, D., Ohtsuki, M., Maul, J.-T., Szegedi, A., Luna, P. C., Lynde, C. W., Soliman, A. M., Wang, H., Kaufmann, C., Ashley, D. G., et al. (2025). “Correction: Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months” in Dermatology and Therapy.

Wuzheng Zhu | Qualitative Research | Research Excellence Award

Published on by Research Data Analysis

Dr. Wuzheng Zhu | Qualitative Research | Research Excellence Award

College of Life Sciences | China

Dr. Wuzheng Zhu is a regenerative medicine researcher, specializing in mitochondrial biology, cellular repair, and stem‑cell therapies. He earned his Ph.D. in Biochemistry and Molecular Biology from Sichuan University’s Regenerative Medicine Research Center (West China Hospital). Currently based in the Laboratory of Animal Nutrition and Human Health, College of Life Sciences, Changsha, his work delves into the molecular mechanisms underlying mitochondrial homeostasis, particularly in the context of acute kidney injury and cardiovascular diseases. His lab combines biochemistry, molecular and cellular biology, drug screening, and mouse models to identify and manipulate mitochondrial regulation and repair pathways. Dr. Zhu has published extensively, with 5 documents, 306 citations, and an h‑index of 5, including influential studies on mesenchymal stem cell–mediated protection via mitophagy, mitochondrial dynamics in endothelial injury, lysosomal dysfunction in macrophage polarization, and suppression of ER stress in vascular cells. He has also investigated dietary intervention in piglet gut development. He is a recipient of the prestigious TTS‑CTRMS Scientific Congress Award in 2017. His research offers significant translational potential, aiming to harness mitochondrial modulation and stem-cell strategies for therapeutic intervention in metabolic and cardiovascular conditions.

Profile : Scopus

Featured Publications

Wei, J., Mao, R., Chen, Y., Si, K., Li, Y., Li, J., & Zhu, W. (2025). “MSCs ameliorates hyperglycemia-induced endothelial injury through modulation of mitochondrial dynamics” in Cell Death & Disease, 16(1), 832.

Mao, R.W., He, S.P., Lan, J.G., & Zhu, W.Z. (2022). “Honokiol ameliorates cisplatin‐induced acute kidney injury via inhibition of mitochondrial fission” in British Journal of Pharmacology.

Zhu, W., Yuan, Y., Liao, G., Li, L., Liu, J., Chen, Y., et al. (2018). “Mesenchymal stem cells ameliorate hyperglycemia-induced endothelial injury through modulation of mitophagy” in Cell Death & Disease, 9(8), 1–17.

Yuan, Y., Chen, Y., Peng, T., Li, L., Zhu, W., Liu, F., et al. (2019). “Mitochondrial ROS-induced lysosomal dysfunction impairs autophagic flux and contributes to M1 macrophage polarization in a diabetic condition” in Clinical Science, 133(15), 1759–1777.

Luo, R., Li, L., Liu, X., Yuan, Y., Zhu, W., Li, L., et al. (2020). “Mesenchymal stem cells alleviate palmitic acid-induced endothelial-to-mesenchymal transition by suppressing endoplasmic reticulum stress” in American Journal of Physiology-Endocrinology and Metabolism, 319(6), E961–E980.

Zhifen Chen | Public Health Analytics | Best Researcher Award

Published on by Research Data Analysis

Dr. Zhifen Chen | Public Health Analytics | Best Researcher Award

German Heart Center, TUM University Hospital, Technical University of Munich (TUM) | Germany

Dr. Zhifen Chen is an Independent Junior Group Leader at the German Heart Center, Technical University of Munich, specializing in experimental cardiology. She earned her Bachelor’s degree in Life Sciences from Hubei Normal University and a Master of Science from Tsinghua University. Dr. Chen completed her PhD at the Technical University of Munich with a summa cum laude distinction, focusing on human iPSC-derived cardiomyocytes for cardiac disease modeling, therapeutic discovery, and safety pharmacology. She pursued postdoctoral research at Harvard University and the Beth Israel Deaconess Medical Center, contributing to functional genomics, CRISPR-based screening, and cardiovascular disease studies. Her research focuses on the genetics and molecular mechanisms of coronary artery disease, adipose tissue biology, insulin resistance, and cardiovascular precision medicine. Dr. Chen has secured multiple competitive grants, including from the DFG, DZHK, and international cardiovascular research partnerships. She has received numerous awards and honors, such as PhD summa cum laude, international travel awards, and conference prizes. She actively supervises postdoctoral researchers, PhD, MD, Master, and Bachelor students, and contributes to scientific communities as a reviewer, consortium member, and workshop organizer. Dr. Chen’s work integrates genome editing, transcriptomics, and advanced in vitro models to identify novel therapeutic targets, advancing cardiovascular research and translational medicine.

Profile : Orcid

Featured Publications

von Scheidt, M., Adkar, S. S., Krefting, J., Hoermann, G., Meggendorfer, M., Bauer, S., Mitchell, S., Pugach, I., Friess, C., Ma, A., et al. (2025). “Clonal Haematopoiesis of Indeterminate Potential and Mortality in Coronary Artery Disease.” European Heart Journal.

Xu, C., Nie, X., Chen, Z., Qu, J. Z., & Wang, D. (2025). “Stenotic Left Atrioventricular Valve after Atrioventricular Septal Defect Repair: A Distinct Surgical Phenotype.” The Journal of Thoracic and Cardiovascular Surgery.

Chen, Z., Li, S., Song, X., Diagel, A., Li, L., Moggio, A., Li, Z., Chen, Y., Dang, T., Li, M., et al. (2025). “An Interplay of Non-Coding RNAs Regulates CDH13 Expression and Affects Endothelial Function and Coronary Artery Disease Risk.” Preprint.

Byers, P., Kellerer, T., Li, M., Chen, Z., Huser, T., & Hellerer, T. (2025). “Super-Resolution Upgrade for Deep Tissue Imaging Featuring Simple Implementation.” Nature Communications.

Sanin, V., Schmieder, R. S., Koenig, W., Li, L., Schunkert, H., & Chen, Z. (2025). “Rolle der Genetik in der Präzisionsmedizin der Koronaren Herzkrankheit.” Herz.

Tze-Woei Tan | Healthcare Data Analysis | Best Researcher Award

Published on by Research Data Analysis

Dr. Tze-Woei Tan | Healthcare Data Analysis | Best Researcher Award

University of Southern California | United States

Dr. Tze-Woei Tan is an Associate Professor of Clinical Surgery at the Keck School of Medicine of USC and Director of the Limb Salvage Research Program. He obtained his MBBS at the University of Melbourne (2002), completed general surgery training at Brown University (2010) and a vascular surgery fellowship at Boston University School of Medicine (2012), and later earned a Master of Public Health in Health Promotion (2020). His academic career includes an Assistant Professorship at the Louisiana State University Health Science Center (2012-16) and an Associate Professorship at the University of Arizona College of Medicine (2020-22) before his current role at USC. His research focuses on health services, access to care, health equity, and particularly limb preservation in patients with diabetes and peripheral artery disease, securing major NIH and foundation-funded grants in these areas. Among his recognitions are the Roger Pecoraro Award (American Diabetes Association, 2023) and the Faculty Teaching Award at Keck (2024). According to publicly available data his publication record spans from 2007 to 2025 and he is credited with an h-index of ~25, around 2,597 citations, and approximately 124 documents (note: bibliometric values vary by database and may be approximate). In sum, Dr. Tan merges specialist operative vascular surgery with a strong public-health and equity orientation, leading interdisciplinary efforts to reduce amputations and improve vascular care in underserved populations.

Profiles : Scopus | Orcid

Featured Publications

Bolakale-Rufai, I.K., French, S.R., Knapp, S.M., Thompson, M., Arias, J.C., Garcia-Filion, P., Ainapurapu, B., Tan, T.-W., & Weinkauf, C.C. (2025). “Stratification of Clinical Microvascular Disease Severity Using Non-Invasive Monofilament Testing in Patients with Type 2 Diabetes Mellitus” in Diabetology, 6(4). DOI: 10.3390/diabetology6040024.

Luu, I.Y., Hong, A.T., Lee, A., Arias, J.C., Shih, C.-D., Armstrong, D.G., & Tan, T.-W. (2024). “Improved Diabetic Foot Ulcer Outcomes in Medicaid Beneficiaries with Podiatric Care Access” in Diabetology, 5(5). DOI: 10.3390/diabetology5050036.

Kwon, K., Brown, T.A., Arias Aristizábal, J.C., Armstrong, D.G., & Tan, T.-W. (2024). “Outcomes for Patients with Diabetic Foot Ulcers Following Transition from Medicaid to Commercial Insurance” in Diabetology, 5(3). DOI: 10.3390/diabetology5030027.

Finco, M.G., Cay, G., Lee, M., Garcia, J., Salazar, E., Tan, T.-W., Armstrong, D.G., & Najafi, B. (2023). “Taking a Load Off: User Perceptions of Smart Offloading Walkers for Diabetic Foot Ulcers Using the Technology Acceptance Model” in Sensors, 23(5), 2768. DOI: 10.3390/s23052768.

Tan, T.-W., Armstrong, D.G., & collaborators. (2022). “Rates of Diabetes-Related Major Amputations Among Racial and Ethnic Minority Adults Following Medicaid Expansion Under the Patient Protection and Affordable Care Act” in JAMA Network Open, 5(3), e223991. DOI: 10.1001/jamanetworkopen.2022.3991. PMID: 35323948.

Beatriz Barquiel Alcalá | Qualitative Research | Best Research Article Award

Published on by Research Data Analysis

Dr. Beatriz Barquiel Alcalá | Qualitative Research | Best Research Article Award

Hospital Universitario La Paz | Spain

Dr. Beatriz Barquiel Alcalá is a physician-scientist specializing in endocrinology and nutrition, with a clinical appointment since 2010 at Hospital Universitario La Paz in Madrid. She holds a Licentiate in Medicine and Surgery from the University of Granada (2005) and completed further training under RD 99/2011 at the Universidad Autónoma de Madrid in 2012. Over her career she has published widely on diabetes and pregnancy, gestational and pregestational diabetes, maternal weight gain, and metabolic outcomes, including contributions as corresponding author. Her work spans over 30 scientific articles (e.g. on glycemic control, gestational weight gain, twin versus singleton pregnancies, neonatal outcomes, continuous glucose monitoring) as well as book chapters on hypertensive disorders, exercise in gestational diabetes, and obesity in pregnancy. She has led or participated in multiple funded projects—among them randomized trials and studies on biomarker validation, dietary interventions in pregnancy, and predictors of glycemic control. She also undertook a research stay at Memorial Sloan Kettering (USA) in 2009–2010. Her research interests lie at the intersection of maternal–fetal medicine, diabetes, metabolic programming, and endocrinology innovations.

Profile : Scopus

Featured Publications

Aguilera-García, I., Barquiel-Alcalá, B., Vázquez-Pérez, P., Prados-Sánchez, M.C., & González-Pérez de Villar, N. (2025). Time to change guidelines? Suboptimal glycemic control measures by CGM associated with cystic fibrosis exacerbations despite adequate HbA1c. Acta Diabetológica.

Borrego Soriano, I., Barquiel-Alcalá, B., Moreno-Domínguez, O., Qasem Moreno, A.L., García-Pérez de Sevilla, E., & González-Pérez de Villar, N. (2025). Screening system for the detection of unknown or poorly controlled diabetes mellitus in a tertiary hospital: A retrospective study. Journal of Evaluation in Clinical Practice.

Quirós, C., Herrera, M.T., Amigó, J., Perea, V., Barquiel, B., et al. (2024). Real-world evidence of off-label use of commercially automated insulin delivery systems compared to multiple daily insulin injections in pregnancies complicated by type 1 diabetes. Diabetes Technology & Therapeutics.

Barquiel, B. (AC), Calvo, M., Moreno-Domínguez, O., Bartha, J.L., et al. (2023). The PREDG study: A randomised controlled trial testing whether an educational intervention can prevent gestational weight gain in women with obesity. Clinical Nutrition ESPEN.

García-Moreno, C., Benítez-Valderrama, P., Barquiel, B., González-Pérez de Villar, N., Hillman, N., Lora Pablos, A., & Herranz, L. (2022). Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: A systematic review and meta-analysis of randomized clinical trials. Diabetic Medicine.